{"id":"bpdo-1603","safety":{"commonSideEffects":[{"rate":"null","effect":"Cough"},{"rate":"null","effect":"Dizziness"},{"rate":"null","effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL587788","moleculeType":"Small molecule","molecularWeight":"430.49"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"BPDO-1603 works by inhibiting the angiotensin-converting enzyme (ACE), which is a key component of the renin-angiotensin system. This inhibition leads to decreased levels of angiotensin II, a potent vasoconstrictor, resulting in vasodilation and reduced blood pressure.","oneSentence":"BPDO-1603 is a small molecule that targets the renin-angiotensin system to lower blood pressure.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:42:08.905Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertension"}]},"trialDetails":[{"nctId":"NCT05804279","phase":"PHASE1","title":"Pharmacokinetics of BPDO-1603 or BPDO-16031 and BPDO-16033 Administration in Healthy Adults","status":"COMPLETED","sponsor":"Hyundai Pharm","startDate":"2022-12-28","conditions":"Healthy","enrollment":24},{"nctId":"NCT04229927","phase":"PHASE3","title":"BPDO-1603 Intervention Trial in Patients With Moderate-to-severe Alzheimer's Disease","status":"UNKNOWN","sponsor":"Hyundai Pharmaceutical Co., LTD.","startDate":"2020-02-27","conditions":"Moderate-to-severe Alzheimer's Disease","enrollment":712}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"BPDO-1603","genericName":"BPDO-1603","companyName":"Hyundai Pharmaceutical Co., LTD.","companyId":"hyundai-pharmaceutical-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"BPDO-1603 is a small molecule that targets the renin-angiotensin system to lower blood pressure. Used for Hypertension.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}